Nafarelin in the treatment of infertility caused by endometriosis

Patients with infertility caused by endometriosis may be managed by expectant strategies, surgery, or pharmacologic intervention. The relative benefits conferred by each of these approaches remain to be confirmed. Data gathered thus far suggest, however, that nafarelin, a gonadotropin-releasing hormone agonist, may be associated with fecundity rates as low as those seen after surgical intervention.